NIPPON INDIA PHARMA FUND - GROWTH PLAN - GROWTH OPTION

NORMAL RISK
Equity
Equity: Sectoral-Pharma
6M returns
18.06 %
Current NAV
434.33
1M3M6M1Y3Y5YALL
Loading...
Min. SIP
5000
AUM
₹ 7132.8 Cr

Return Calculator

Amount per month5,000
Over the past
1Y
3Y
5Y
Return amount NA
Total Investment
60,000

Investment distribution

Sun Pharmaceutical Industries12.8 %
Lupin7.8 %
Cipla6.0 %
Apollo Hospitals Enterprise5.7 %
Gland Pharma5.1 %
Dr. Reddy's Laboratories4.9 %

Fund Manager

SR
Sailesh Raj Bhan
AS
Akshay Sharma

Fund Information

Launched
18 Jul 2010(13 years ago)
Expense ratio1.88%
Exit LoadExit load of 1% if redeemed within 1 month.
Benchmark index
S&P BSE Healthcare TRI100%

Fund Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Copyright ⓒ 2024 Cherry. All rights reserved.
appstoreplaystore